img

Global Glucosylceramidase Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Glucosylceramidase Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Glucosylceramidase report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Glucosylceramidase market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Genetic Disorders and Gaucher Disease are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Glucosylceramidase industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Glucosylceramidase key manufacturers include Amicus Therapeutics, Inc., Bioorganic Research and Services S.A., greenovation Biotech GmbH, JCR Pharmaceuticals Co., Ltd., Pharming Group N.V., Protalix BioTherapeutics, Inc., Takeda and The International Biotechnology Center (IBC) Generium, etc. Amicus Therapeutics, Inc., Bioorganic Research and Services S.A., greenovation Biotech GmbH are top 3 players and held % sales share in total in 2022.
Glucosylceramidase can be divided into AVRRD-02, LTI-291, NCGC-607 and Pcgin, etc. AVRRD-02 is the mainstream product in the market, accounting for % sales share globally in 2022.
Glucosylceramidase is widely used in various fields, such as Genetic Disorders, Gaucher Disease, Parkinson's Disease and Others, etc. Genetic Disorders provides greatest supports to the Glucosylceramidase industry development. In 2022, global % sales of Glucosylceramidase went into Genetic Disorders filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Glucosylceramidase market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Amicus Therapeutics, Inc.
Bioorganic Research and Services S.A.
greenovation Biotech GmbH
JCR Pharmaceuticals Co., Ltd.
Pharming Group N.V.
Protalix BioTherapeutics, Inc.
Takeda
The International Biotechnology Center (IBC) Generium
Segment by Type
AVRRD-02
LTI-291
NCGC-607
Pcgin
Others

Segment by Application


Genetic Disorders
Gaucher Disease
Parkinson's Disease
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Glucosylceramidase market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Glucosylceramidase, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Glucosylceramidase industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Glucosylceramidase in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Glucosylceramidase introduction, etc. Glucosylceramidase Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Glucosylceramidase market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Glucosylceramidase Market Overview
1.1 Glucosylceramidase Product Overview
1.2 Glucosylceramidase Market Segment by Type
1.2.1 AVRRD-02
1.2.2 LTI-291
1.2.3 NCGC-607
1.2.4 Pcgin
1.2.5 Others
1.3 Global Glucosylceramidase Market Size by Type
1.3.1 Global Glucosylceramidase Market Size Overview by Type (2018-2034)
1.3.2 Global Glucosylceramidase Historic Market Size Review by Type (2018-2024)
1.3.3 Global Glucosylceramidase Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Glucosylceramidase Sales Breakdown by Type (2018-2024)
1.4.2 Europe Glucosylceramidase Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Glucosylceramidase Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Glucosylceramidase Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Glucosylceramidase Sales Breakdown by Type (2018-2024)
2 Global Glucosylceramidase Market Competition by Company
2.1 Global Top Players by Glucosylceramidase Sales (2018-2024)
2.2 Global Top Players by Glucosylceramidase Revenue (2018-2024)
2.3 Global Top Players by Glucosylceramidase Price (2018-2024)
2.4 Global Top Manufacturers Glucosylceramidase Manufacturing Base Distribution, Sales Area, Product Type
2.5 Glucosylceramidase Market Competitive Situation and Trends
2.5.1 Glucosylceramidase Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Glucosylceramidase Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Glucosylceramidase as of 2022)
2.7 Date of Key Manufacturers Enter into Glucosylceramidase Market
2.8 Key Manufacturers Glucosylceramidase Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Glucosylceramidase Status and Outlook by Region
3.1 Global Glucosylceramidase Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Glucosylceramidase Historic Market Size by Region
3.2.1 Global Glucosylceramidase Sales in Volume by Region (2018-2024)
3.2.2 Global Glucosylceramidase Sales in Value by Region (2018-2024)
3.2.3 Global Glucosylceramidase Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Glucosylceramidase Forecasted Market Size by Region
3.3.1 Global Glucosylceramidase Sales in Volume by Region (2024-2034)
3.3.2 Global Glucosylceramidase Sales in Value by Region (2024-2034)
3.3.3 Global Glucosylceramidase Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Glucosylceramidase by Application
4.1 Glucosylceramidase Market Segment by Application
4.1.1 Genetic Disorders
4.1.2 Gaucher Disease
4.1.3 Parkinson's Disease
4.1.4 Others
4.2 Global Glucosylceramidase Market Size by Application
4.2.1 Global Glucosylceramidase Market Size Overview by Application (2018-2034)
4.2.2 Global Glucosylceramidase Historic Market Size Review by Application (2018-2024)
4.2.3 Global Glucosylceramidase Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Glucosylceramidase Sales Breakdown by Application (2018-2024)
4.3.2 Europe Glucosylceramidase Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Glucosylceramidase Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Glucosylceramidase Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Glucosylceramidase Sales Breakdown by Application (2018-2024)
5 North America Glucosylceramidase by Country
5.1 North America Glucosylceramidase Historic Market Size by Country
5.1.1 North America Glucosylceramidase Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Glucosylceramidase Sales in Volume by Country (2018-2024)
5.1.3 North America Glucosylceramidase Sales in Value by Country (2018-2024)
5.2 North America Glucosylceramidase Forecasted Market Size by Country
5.2.1 North America Glucosylceramidase Sales in Volume by Country (2024-2034)
5.2.2 North America Glucosylceramidase Sales in Value by Country (2024-2034)
6 Europe Glucosylceramidase by Country
6.1 Europe Glucosylceramidase Historic Market Size by Country
6.1.1 Europe Glucosylceramidase Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Glucosylceramidase Sales in Volume by Country (2018-2024)
6.1.3 Europe Glucosylceramidase Sales in Value by Country (2018-2024)
6.2 Europe Glucosylceramidase Forecasted Market Size by Country
6.2.1 Europe Glucosylceramidase Sales in Volume by Country (2024-2034)
6.2.2 Europe Glucosylceramidase Sales in Value by Country (2024-2034)
7 Asia-Pacific Glucosylceramidase by Region
7.1 Asia-Pacific Glucosylceramidase Historic Market Size by Region
7.1.1 Asia-Pacific Glucosylceramidase Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Glucosylceramidase Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Glucosylceramidase Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Glucosylceramidase Forecasted Market Size by Region
7.2.1 Asia-Pacific Glucosylceramidase Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Glucosylceramidase Sales in Value by Region (2024-2034)
8 Latin America Glucosylceramidase by Country
8.1 Latin America Glucosylceramidase Historic Market Size by Country
8.1.1 Latin America Glucosylceramidase Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Glucosylceramidase Sales in Volume by Country (2018-2024)
8.1.3 Latin America Glucosylceramidase Sales in Value by Country (2018-2024)
8.2 Latin America Glucosylceramidase Forecasted Market Size by Country
8.2.1 Latin America Glucosylceramidase Sales in Volume by Country (2024-2034)
8.2.2 Latin America Glucosylceramidase Sales in Value by Country (2024-2034)
9 Middle East and Africa Glucosylceramidase by Country
9.1 Middle East and Africa Glucosylceramidase Historic Market Size by Country
9.1.1 Middle East and Africa Glucosylceramidase Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Glucosylceramidase Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Glucosylceramidase Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Glucosylceramidase Forecasted Market Size by Country
9.2.1 Middle East and Africa Glucosylceramidase Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Glucosylceramidase Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Amicus Therapeutics, Inc.
10.1.1 Amicus Therapeutics, Inc. Company Information
10.1.2 Amicus Therapeutics, Inc. Introduction and Business Overview
10.1.3 Amicus Therapeutics, Inc. Glucosylceramidase Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Amicus Therapeutics, Inc. Glucosylceramidase Products Offered
10.1.5 Amicus Therapeutics, Inc. Recent Development
10.2 Bioorganic Research and Services S.A.
10.2.1 Bioorganic Research and Services S.A. Company Information
10.2.2 Bioorganic Research and Services S.A. Introduction and Business Overview
10.2.3 Bioorganic Research and Services S.A. Glucosylceramidase Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Bioorganic Research and Services S.A. Glucosylceramidase Products Offered
10.2.5 Bioorganic Research and Services S.A. Recent Development
10.3 greenovation Biotech GmbH
10.3.1 greenovation Biotech GmbH Company Information
10.3.2 greenovation Biotech GmbH Introduction and Business Overview
10.3.3 greenovation Biotech GmbH Glucosylceramidase Sales, Revenue and Gross Margin (2018-2024)
10.3.4 greenovation Biotech GmbH Glucosylceramidase Products Offered
10.3.5 greenovation Biotech GmbH Recent Development
10.4 JCR Pharmaceuticals Co., Ltd.
10.4.1 JCR Pharmaceuticals Co., Ltd. Company Information
10.4.2 JCR Pharmaceuticals Co., Ltd. Introduction and Business Overview
10.4.3 JCR Pharmaceuticals Co., Ltd. Glucosylceramidase Sales, Revenue and Gross Margin (2018-2024)
10.4.4 JCR Pharmaceuticals Co., Ltd. Glucosylceramidase Products Offered
10.4.5 JCR Pharmaceuticals Co., Ltd. Recent Development
10.5 Pharming Group N.V.
10.5.1 Pharming Group N.V. Company Information
10.5.2 Pharming Group N.V. Introduction and Business Overview
10.5.3 Pharming Group N.V. Glucosylceramidase Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Pharming Group N.V. Glucosylceramidase Products Offered
10.5.5 Pharming Group N.V. Recent Development
10.6 Protalix BioTherapeutics, Inc.
10.6.1 Protalix BioTherapeutics, Inc. Company Information
10.6.2 Protalix BioTherapeutics, Inc. Introduction and Business Overview
10.6.3 Protalix BioTherapeutics, Inc. Glucosylceramidase Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Protalix BioTherapeutics, Inc. Glucosylceramidase Products Offered
10.6.5 Protalix BioTherapeutics, Inc. Recent Development
10.7 Takeda
10.7.1 Takeda Company Information
10.7.2 Takeda Introduction and Business Overview
10.7.3 Takeda Glucosylceramidase Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Takeda Glucosylceramidase Products Offered
10.7.5 Takeda Recent Development
10.8 The International Biotechnology Center (IBC) Generium
10.8.1 The International Biotechnology Center (IBC) Generium Company Information
10.8.2 The International Biotechnology Center (IBC) Generium Introduction and Business Overview
10.8.3 The International Biotechnology Center (IBC) Generium Glucosylceramidase Sales, Revenue and Gross Margin (2018-2024)
10.8.4 The International Biotechnology Center (IBC) Generium Glucosylceramidase Products Offered
10.8.5 The International Biotechnology Center (IBC) Generium Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Glucosylceramidase Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Glucosylceramidase Industrial Chain Analysis
11.4 Glucosylceramidase Market Dynamics
11.4.1 Glucosylceramidase Industry Trends
11.4.2 Glucosylceramidase Market Drivers
11.4.3 Glucosylceramidase Market Challenges
11.4.4 Glucosylceramidase Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Glucosylceramidase Distributors
12.3 Glucosylceramidase Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of AVRRD-02
Table 2. Major Company of LTI-291
Table 3. Major Company of NCGC-607
Table 4. Major Company of Pcgin
Table 5. Major Company of Others
Table 6. Global Glucosylceramidase Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Glucosylceramidase Sales by Type (2018-2024) & (K Pcs)
Table 8. Global Glucosylceramidase Sales Market Share in Volume by Type (2018-2024)
Table 9. Global Glucosylceramidase Sales by Type (2018-2024) & (US& Million)
Table 10. Global Glucosylceramidase Market Share in Value by Type (2018-2024)
Table 11. Global Glucosylceramidase Price by Type (2018-2024) & (USD/Pcs)
Table 12. Global Glucosylceramidase Sales by Type (2024-2034) & (K Pcs)
Table 13. Global Glucosylceramidase Sales Market Share in Volume by Type (2024-2034)
Table 14. Global Glucosylceramidase Sales by Type (2024-2034) & (US$ Million)
Table 15. Global Glucosylceramidase Sales Market Share in Value by Type (2024-2034)
Table 16. Global Glucosylceramidase Price by Type (2024-2034) & (USD/Pcs)
Table 17. North America Glucosylceramidase Sales by Type (2018-2024) & (K Pcs)
Table 18. North America Glucosylceramidase Sales by Type (2018-2024) & (US$ Million)
Table 19. Europe Glucosylceramidase Sales (K Pcs) by Type (2018-2024)
Table 20. Europe Glucosylceramidase Sales by Type (2018-2024) & (US$ Million)
Table 21. Asia-Pacific Glucosylceramidase Sales (K Pcs) by Type (2018-2024)
Table 22. Asia-Pacific Glucosylceramidase Sales by Type (2018-2024) & (US$ Million)
Table 23. Latin America Glucosylceramidase Sales (K Pcs) by Type (2018-2024)
Table 24. Latin America Glucosylceramidase Sales by Type (2018-2024) & (US$ Million)
Table 25. Middle East and Africa Glucosylceramidase Sales (K Pcs) by Type (2018-2024)
Table 26. Middle East and Africa Glucosylceramidase Sales by Type (2018-2024) & (US$ Million)
Table 27. Global Glucosylceramidase Sales by Company (2018-2024) & (K Pcs)
Table 28. Global Glucosylceramidase Sales Share by Company (2018-2024)
Table 29. Global Glucosylceramidase Revenue by Company (2018-2024) & (US$ Million)
Table 30. Global Glucosylceramidase Revenue Share by Company (2018-2024)
Table 31. Global Market Glucosylceramidase Price by Company (2018-2024) & (USD/Pcs)
Table 32. Global Glucosylceramidase Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Glucosylceramidase Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Glucosylceramidase as of 2022)
Table 35. Date of Key Manufacturers Enter into Glucosylceramidase Market
Table 36. Key Manufacturers Glucosylceramidase Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Glucosylceramidase Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 39. Global Glucosylceramidase Sales by Region (2018-2024) & (K Pcs)
Table 40. Global Glucosylceramidase Sales Market Share in Volume by Region (2018-2024)
Table 41. Global Glucosylceramidase Sales by Region (2018-2024) & (US$ Million)
Table 42. Global Glucosylceramidase Sales Market Share in Value by Region (2018-2024)
Table 43. Global Glucosylceramidase Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 44. Global Glucosylceramidase Sales by Region (2024-2034) & (K Pcs)
Table 45. Global Glucosylceramidase Sales Market Share in Volume by Region (2024-2034)
Table 46. Global Glucosylceramidase Sales by Region (2024-2034) & (US$ Million)
Table 47. Global Glucosylceramidase Sales Market Share in Value by Region (2024-2034)
Table 48. Global Glucosylceramidase Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 49. Global Glucosylceramidase Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 50. Global Glucosylceramidase Sales by Application (2018-2024) & (K Pcs)
Table 51. Global Glucosylceramidase Sales Market Share in Volume by Application (2018-2024)
Table 52. Global Glucosylceramidase Sales by Application (2018-2024) & (US$ Million)
Table 53. Global Glucosylceramidase Sales Market Share in Value by Application (2018-2024)
Table 54. Global Glucosylceramidase Price by Application (2018-2024) & (USD/Pcs)
Table 55. Global Glucosylceramidase Sales by Application (2024-2034) & (K Pcs)
Table 56. Global Glucosylceramidase Sales Market Share in Volume by Application (2024-2034)
Table 57. Global Glucosylceramidase Sales by Application (2024-2034) & (US$ Million)
Table 58. Global Glucosylceramidase Sales Market Share in Value by Application (2024-2034)
Table 59. Global Glucosylceramidase Price by Application (2024-2034) & (USD/Pcs)
Table 60. North America Glucosylceramidase Sales by Application (2018-2024) (K Pcs)
Table 61. North America Glucosylceramidase Sales by Application (2018-2024) & (US$ Million)
Table 62. Europe Glucosylceramidase Sales by Application (2018-2024) (K Pcs)
Table 63. Europe Glucosylceramidase Sales by Application (2018-2024) & (US$ Million)
Table 64. Asia-Pacific Glucosylceramidase Sales by Application (2018-2024) (K Pcs)
Table 65. Asia-Pacific Glucosylceramidase Sales by Application (2018-2024) & (US$ Million)
Table 66. Latin America Glucosylceramidase Sales by Application (2018-2024) (K Pcs)
Table 67. Latin America Glucosylceramidase Sales by Application (2018-2024) & (US$ Million)
Table 68. Middle East and Africa Glucosylceramidase Sales by Application (2018-2024) (K Pcs)
Table 69. Middle East and Africa Glucosylceramidase Sales by Application (2018-2024) & (US$ Million)
Table 70. North America Glucosylceramidase Sales by Country (2018-2024) & (K Pcs)
Table 71. North America Glucosylceramidase Sales Market Share in Volume by Country (2018-2024)
Table 72. North America Glucosylceramidase Sales by Country (2018-2024) & (US$ Million)
Table 73. North America Glucosylceramidase Sales Market Share in Value by Country (2018-2024)
Table 74. North America Glucosylceramidase Sales by Country (2024-2034) & (K Pcs)
Table 75. North America Glucosylceramidase Sales Market Share in Volume by Country (2024-2034)
Table 76. North America Glucosylceramidase Sales by Country (2024-2034) & (US$ Million)
Table 77. North America Glucosylceramidase Sales Market Share in Value by Country (2024-2034)
Table 78. Europe Glucosylceramidase Sales by Country (2018-2024) & (K Pcs)
Table 79. Europe Glucosylceramidase Sales Market Share in Volume by Country (2018-2024)
Table 80. Europe Glucosylceramidase Sales by Country (2018-2024) & (US$ Million)
Table 81. Europe Glucosylceramidase Sales Market Share in Value by Country (2018-2024)
Table 82. Europe Glucosylceramidase Sales by Country (2024-2034) & (K Pcs)
Table 83. Europe Glucosylceramidase Sales Market Share in Volume by Country (2024-2034)
Table 84. Europe Glucosylceramidase Sales by Country (2024-2034) & (US$ Million)
Table 85. Europe Glucosylceramidase Sales Market Share in Value by Country (2024-2034)
Table 86. Asia-Pacific Glucosylceramidase Sales by Region (2018-2024) & (K Pcs)
Table 87. Asia-Pacific Glucosylceramidase Sales Market Share in Volume by Region (2018-2024)
Table 88. Asia-Pacific Glucosylceramidase Sales by Region (2018-2024) & (US$ Million)
Table 89. Asia-Pacific Glucosylceramidase Sales Market Share in Value by Region (2018-2024)
Table 90. Asia-Pacific Glucosylceramidase Sales by Region (2024-2034) & (K Pcs)
Table 91. Asia-Pacific Glucosylceramidase Sales Market Share in Volume by Region (2024-2034)
Table 92. Asia-Pacific Glucosylceramidase Sales by Region (2024-2034) & (US$ Million)
Table 93. Asia-Pacific Glucosylceramidase Sales Market Share in Value by Region (2024-2034)
Table 94. Latin America Glucosylceramidase Sales by Country (2018-2024) & (K Pcs)
Table 95. Latin America Glucosylceramidase Sales Market Share in Volume by Country (2018-2024)
Table 96. Latin America Glucosylceramidase Sales by Country (2018-2024) & (US$ Million)
Table 97. Latin America Glucosylceramidase Sales Market Share in Value by Country (2018-2024)
Table 98. Latin America Glucosylceramidase Sales by Country (2024-2034) & (K Pcs)
Table 99. Latin America Glucosylceramidase Sales Market Share in Volume by Country (2024-2034)
Table 100. Latin America Glucosylceramidase Sales by Country (2024-2034) & (US$ Million)
Table 101. Latin America Glucosylceramidase Sales Market Share in Value by Country (2024-2034)
Table 102. Middle East and Africa Glucosylceramidase Sales by Country (2018-2024) & (K Pcs)
Table 103. Middle East and Africa Glucosylceramidase Sales Market Share in Volume by Country (2018-2024)
Table 104. Middle East and Africa Glucosylceramidase Sales by Country (2018-2024) & (US$ Million)
Table 105. Middle East and Africa Glucosylceramidase Sales Market Share in Value by Country (2018-2024)
Table 106. Middle East and Africa Glucosylceramidase Sales by Country (2024-2034) & (K Pcs)
Table 107. Middle East and Africa Glucosylceramidase Sales Market Share in Volume by Country (2024-2034)
Table 108. Middle East and Africa Glucosylceramidase Sales by Country (2024-2034) & (US$ Million)
Table 109. Middle East and Africa Glucosylceramidase Sales Market Share in Value by Country (2024-2034)
Table 110. Amicus Therapeutics, Inc. Company Information
Table 111. Amicus Therapeutics, Inc. Introduction and Business Overview
Table 112. Amicus Therapeutics, Inc. Glucosylceramidase Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 113. Amicus Therapeutics, Inc. Glucosylceramidase Product
Table 114. Amicus Therapeutics, Inc. Recent Development
Table 115. Bioorganic Research and Services S.A. Company Information
Table 116. Bioorganic Research and Services S.A. Introduction and Business Overview
Table 117. Bioorganic Research and Services S.A. Glucosylceramidase Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 118. Bioorganic Research and Services S.A. Glucosylceramidase Product
Table 119. Bioorganic Research and Services S.A. Recent Development
Table 120. greenovation Biotech GmbH Company Information
Table 121. greenovation Biotech GmbH Introduction and Business Overview
Table 122. greenovation Biotech GmbH Glucosylceramidase Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 123. greenovation Biotech GmbH Glucosylceramidase Product
Table 124. greenovation Biotech GmbH Recent Development
Table 125. JCR Pharmaceuticals Co., Ltd. Company Information
Table 126. JCR Pharmaceuticals Co., Ltd. Introduction and Business Overview
Table 127. JCR Pharmaceuticals Co., Ltd. Glucosylceramidase Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 128. JCR Pharmaceuticals Co., Ltd. Glucosylceramidase Product
Table 129. JCR Pharmaceuticals Co., Ltd. Recent Development
Table 130. Pharming Group N.V. Company Information
Table 131. Pharming Group N.V. Introduction and Business Overview
Table 132. Pharming Group N.V. Glucosylceramidase Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 133. Pharming Group N.V. Glucosylceramidase Product
Table 134. Pharming Group N.V. Recent Development
Table 135. Protalix BioTherapeutics, Inc. Company Information
Table 136. Protalix BioTherapeutics, Inc. Introduction and Business Overview
Table 137. Protalix BioTherapeutics, Inc. Glucosylceramidase Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 138. Protalix BioTherapeutics, Inc. Glucosylceramidase Product
Table 139. Protalix BioTherapeutics, Inc. Recent Development
Table 140. Takeda Company Information
Table 141. Takeda Introduction and Business Overview
Table 142. Takeda Glucosylceramidase Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 143. Takeda Glucosylceramidase Product
Table 144. Takeda Recent Development
Table 145. The International Biotechnology Center (IBC) Generium Company Information
Table 146. The International Biotechnology Center (IBC) Generium Introduction and Business Overview
Table 147. The International Biotechnology Center (IBC) Generium Glucosylceramidase Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 148. The International Biotechnology Center (IBC) Generium Glucosylceramidase Product
Table 149. The International Biotechnology Center (IBC) Generium Recent Development
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Glucosylceramidase Market Trends
Table 153. Glucosylceramidase Market Drivers
Table 154. Glucosylceramidase Market Challenges
Table 155. Glucosylceramidase Market Restraints
Table 156. Glucosylceramidase Distributors List
Table 157. Glucosylceramidase Downstream Customers
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Glucosylceramidase Product Picture
Figure 2. Global Glucosylceramidase Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Glucosylceramidase Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Glucosylceramidase Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of AVRRD-02
Figure 6. Global AVRRD-02 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of LTI-291
Figure 8. Global LTI-291 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of NCGC-607
Figure 10. Global NCGC-607 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of Pcgin
Figure 12. Global Pcgin Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Product Picture of Others
Figure 14. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 15. Global Glucosylceramidase Sales by Type (2018-2034) & (US$ Million)
Figure 16. Global Glucosylceramidase Sales Market Share by Type in 2022 & 2034
Figure 17. North America Glucosylceramidase Sales Market Share in Volume by Type in 2022
Figure 18. North America Glucosylceramidase Sales Market Share in Value by Type in 2022
Figure 19. Europe Glucosylceramidase Sales Market Share in Volume by Type in 2022
Figure 20. Europe Glucosylceramidase Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Glucosylceramidase Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Glucosylceramidase Sales Market Share in Value by Type in 2022
Figure 23. Latin America Glucosylceramidase Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Glucosylceramidase Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Glucosylceramidase Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Glucosylceramidase Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Glucosylceramidase Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Glucosylceramidase Revenue in 2022
Figure 29. Glucosylceramidase Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Product Picture of Genetic Disorders
Figure 31. Global Genetic Disorders Sales YoY Growth (2018-2034) & (K Pcs)
Figure 32. Product Picture of Gaucher Disease
Figure 33. Global Gaucher Disease Sales YoY Growth (2018-2034) & (K Pcs)
Figure 34. Product Picture of Parkinson's Disease
Figure 35. Global Parkinson's Disease Sales YoY Growth (2018-2034) & (K Pcs)
Figure 36. Product Picture of Others
Figure 37. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 38. Global Glucosylceramidase Sales by Application (2018-2034) & (US$ Million)
Figure 39. Global Glucosylceramidase Sales Market Share by Application in 2022 & 2034
Figure 40. North America Glucosylceramidase Sales Market Share in Volume by Application in 2022
Figure 41. North America Glucosylceramidase Sales Market Share in Value by Application in 2022
Figure 42. Europe Glucosylceramidase Sales Market Share in Volume by Application in 2022
Figure 43. Europe Glucosylceramidase Sales Market Share in Value by Application in 2022
Figure 44. Asia-Pacific Glucosylceramidase Sales Market Share in Volume by Application in 2022
Figure 45. Asia-Pacific Glucosylceramidase Sales Market Share in Value by Application in 2022
Figure 46. Latin America Glucosylceramidase Sales Market Share in Volume by Application in 2022
Figure 47. Latin America Glucosylceramidase Sales Market Share in Value by Application in 2022
Figure 48. Middle East and Africa Glucosylceramidase Sales Market Share in Value by Application in 2022
Figure 49. Key Raw Materials Price
Figure 50. Glucosylceramidase Manufacturing Cost Structure
Figure 51. Glucosylceramidase Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries